Related Experiment Video
Updated: May 26, 2026
07:17
Single Port Donor Nephrectomy
Published on: March 12, 2011
Initial experience with retroperitoneal laparoendoscopic single-site surgery for upper urinary tract surgery
Chul-Ho Pak1, Seung Baik, Chul Sung Kim
1Department of Urology, Chosun University College of Medicine, Gwangju, Korea.
Korean Journal of Urology
|January 5, 2012
Summary
Retroperitoneal laparoendoscopic single-site surgery (RLESS) is a safe and feasible option for upper urinary tract procedures. Initial outcomes show promising results for patients undergoing RLESS, with minimal complications observed.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Surgical Technology
Background:
- Laparoscopic surgery has advanced significantly, with single-site approaches offering potential benefits.
- Retroperitoneal laparoendoscopic single-site surgery (RLESS) is an emerging technique for accessing the upper urinary tract.
Purpose of the Study:
- To evaluate the initial clinical experience and perioperative outcomes of RLESS for upper urinary tract surgery.
- To assess the feasibility and safety of RLESS in a series of patients.
Main Methods:
- RLESS was performed on 23 patients for indications including nephrectomy and renal cyst ablation using a homemade single-port device.
- Data collected included operative time, blood loss, pain scores (VAPS), and hospital stay.
Main Results:
- The procedure was completed in 23 patients, with one conversion to open surgery due to adhesions.
- Mean operative times ranged from 70.5 to 230 minutes, with low Visual Analogue Pain Scale (VAPS) scores (0.8-2.6).
- Hospital stays averaged 3.2 to 6.0 days, and no major perioperative complications were reported.
Conclusions:
- RLESS is a technically feasible and safe approach for upper urinary tract surgery.
- Further comparative studies are warranted to validate the benefits of RLESS against conventional laparoscopic techniques.
